维普中文期刊产品整合服务
33篇 您的检索式:作者名="AA Hurwitz"
    题名 作者 年代 出处 被引量
1Immune suppression in the tumor micro- environment: a role for dendritic cell-mediated tolerization of T cells显示文摘Hurwitz AA Watkins SK 2012Cancer Immunol Immunother2012,61,2:1
2Immune suppression in the tumormicroenvironment: a role for dendritic cell-mediated tolerization of T cells 显示文摘Hurwitz AA Watkins SK 2012Cancer Immunol Immunotherapy2012,61,2:1
3CIIA-4 blockade synergizes with tumor-derived granulocyte-macrophage colonystimulating factor for treatment of an experimental mammary carcinoma 显示文摘Hurwitz AA Yu TF Leach DR 1998Proc Nail Acad Sci U S A1998,95,10:1
4Combination immunothera-py of primary prostate cancer in a transgenic mouse model using CT- LA - 4 blockade 显示文摘Hurwitz AA Foster BA Kwon ED 2000Cancer Res2000,60,9:1
5Elimination of residual me- tastatic prostate cancer after surgery and adjunctive cytotoxic T lym- phocyte - associated antigen 4 ( CTLA - 4) blockade immunothera- py 显示文摘Kwon ED Foster BA Hurwitz AA 1999Proc Natl Acad Sci USA1999,96,15:1
6Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated anti- gen 4 ( CTLA - 4) and granulocyte/macrophage colony-stimulating factor ( GM - CSF) -producing vaccines induces rejection of subcu- taneous and metastatic tumors accompanied by autoimmune depig- mentation 显示文摘Van Elsas A Hurwitz AA Allison JP 1999J Exp Med1999,190,3:1
7Costimulatory wars: The tumor menace 显示文摘Hurwitz AA Kwon ED van Elsas A 2000Curr Opin Immunol2000,12,5:1
8Combination im-munotherapy of B16 melanoma using anti-cytotoxic T lympho-cyte-associated antigen 4(CTLA-4) and granulocyte/macrophagecolony-stimulating factor (GM-CSF) -producing vaccines in-duces rejection of subcutaneous and metastatic tumors accom-panied by autoimmune depigmentation 显示文摘Van Elsas A Hurwitz AA Allison JP 1999J Exp Med1999,190,3:1
9Enhancement of the anti-tumor immune response using a combination of interferongamma and B7 expression in an experimental mammary carcinoma 显示文摘Hurwitz AA Townsend SE Yu TF 1998Int J Cancer1998,77,1:1
10CTLA-4 blockade synergizes with tumor-derived GM-CSF for treatment of experimental mammary carcinoma显示文摘Hurwitz AA Yu TFY Leach DR 1998PNAS1998,95,10:1
11A case series of patients with endometrial insufficiency treated with pentoxifylline and alpha-tocopherol 显示文摘Okusami AA Moore ME Hurwitz JM 2007Fertil Steril2007,88,1:1
12Immune suppression in the tumor mi- croenvironment: a role for dendritic cell-mediated tderization of T cells 显示文摘Hurwitz AA Watkins SK 2012Cancer Immunol Immunother2012,61,2:1
13Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade显示文摘HURWITZ AA FOSTER BA KWON ED 2000Cancer Res2000,60,9:1
14Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy显示文摘KWON ED FOSTER BA HURWITZ AA 1999Proc Natl Acad Sci USA1999,96,15:1
15Combination immunotherapy of BI6 melanoma using anti-cytotoxic T lymphocyteassociated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF) -producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation显示文摘VAN ELSAS A HURWITZ AA ALLISONJP 1999J Exp Med1999,190,3:1
16Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes显示文摘Hurwitz AA Lyman WD Guida MP 1992Exp Med1992,176,6:1
17Tumor-induced immune suppression显示文摘DI Gabrilovich AA Hurwitz 2008Springer2008,93,2:1
18Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade 显示文摘Hurwitz AA Foster BA Kwon ED 2000Cancer Res2000,60,:1
19Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 ( CTLA-4 ) blockade immunotherapy显示文摘Kwon ED Foster BA Hurwitz AA 1999Proc Nail Acad Sci USA1999,96,15:1
20Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade显示文摘Hurwitz AA Foster BA Kwon ED 2000Cancer Res2000,60,9:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费